Cargando…
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
Diabetes mellitus (DM) increases the risk of viral infections especially during the period of poor glycemic controls. Emerging evidence has reported that DM is one of the most common comorbidities in the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection, also referred to as...
Autores principales: | Sun, Bao, Huang, Shiqiong, Zhou, Jiecan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878391/ https://www.ncbi.nlm.nih.gov/pubmed/33584268 http://dx.doi.org/10.3389/fphar.2020.592439 |
Ejemplares similares
-
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022) -
Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
por: Sultanpur, CM, et al.
Publicado: (2010) -
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022) -
Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021) -
Phytochemical Screening and Antidiabetic, Antihyperlipidemic, and Antioxidant Effects of Leptopus Cordifolius Decne. In Diabetic Mice
por: Rahman, Shahid, et al.
Publicado: (2021)